Science Resources RSS Feeds
|
 |
 |
 |
| View Larger Image | Pharmacogenomics in Drug Discovery and Development (Methods in Molecular Biology) | Hardcoverby Qing Yan (Editor)
| List Price: | $99.50 | | | Available: | Usually ships in 24 hours |
| | Binding: | Hardcover | | Publisher: | Humana Press | | Edition: | 1st Edition | | Page Count: | 487 Pages | | Publication Date: | March 19, 2008 | | Sales Rank: | 532,432nd |
|
EDITORIAL REVIEWS |
Product Description
Since each human is genetically distinctive, responding differently to disease-causing factors as well as drugs, the field pharmacogenomics arose to develop personalized medicine, or medicine that deals with the complexity of the human body. In Pharmacogenomics in Drug Discovery and Development, leading experts present methodical, state-of-the-art contributions covering topics from individual molecules to systemic diseases, examining both fundamental concepts and advanced technologies. Divided into three sections, the volume begins by exploring cutting-edge technologies used to pursue systems-based pharmacogenomics, followed by extensive chapters on gene-drug interactions and the use of pharmacogenomics in therapeutics of diseases.Comprehensive and up-to-date, Pharmacogenomics in Drug Discovery and Development is an ideal volume for scientists striving to transform disease treatment into disease prevention. |
CUSTOMER REVIEWS (Average Customer Rating: 5.0 based on 1 review)
|
A timely book on personalized medicine for all levels by Personalized Medicine  5 Stars
June 18, 2008
From fundamental concepts to advanced technologies in pharmacogenomics, this comprehensive book is useful for those interested in personalized medicine at all levels. The book discusses pharmacogenomics in three parts: technologies, molecules, and diseases and treatments. The first part of the book introduces cutting-edge technologies in pharmacogenomics, including bioinformatics, microarray, and association studies. The second part of the book discusses biomarkers and molecules including membrane transporters, receptors, and enzymes. This part includes three chapters on pharmacogenomics of G protein-coupled receptors (GPCR), providing a complete discussion on GPCR genetic variations, their relationships with diseases, and their potential uses as drug targets. The third part of this book focuses on diseases and treatments including psychiatric disorders, cardiovascular diseases, cancer, Alzheimer's disease, gastrointestinal disorders such as inflammatory bowel disease and irritable bowel syndrome, autoimmune diseases such as asthma and rheumatoid arthritis, and infectious diseases and vaccines.
| |
SIMILAR PRODUCTS |
| Pharmacogenomics and Personalized Medicine (Methods in Pharmacology and Toxicology)
by Nadine Cohen (Author), Nadine Cohen (Editor)
With all the multitude of challenges facing the pharmaceutical research and development process, the industry is actively exploring the relationships between human genetics and drug responsiveness, susceptibility to disease and disease severity. In Pharmacogenomics and Personalized Medicine, leading experts from the pharmaceutical industry, the scientific community and the government provide guidance for conducting pharmacogenomic research from discovery to the market, while also presenting...
| 
| Pharmacogenetics (Oxford Monographs on Medical Genetics)
by Wendell Weber (Author)
Drugs are administered to patients with the intention of achieving an expected therapeutic response. Yet drug therapy remains a medical art because of the wide variation in individual responses to standard drug doses. Pharmacogenetics emerged as a field aimed at identifying heritable factors that are predictive of individual variations in drug efficacy and toxicity from the dedicated work of a small group of investigators who in the 1950s began to enrich the discipline of pharmacology by...
| 
| The Innovator's Prescription: A Disruptive Solution for Health Care
by Clayton M. Christensen (Author), Jerome H. Grossman M.D. (Author), Jason Hwang M.D. (Author)
A groundbreaking prescription for health care reform--from a legendary leader in innovation . . . Our health care system is in critical condition. Each year, fewer Americans can afford it, fewer businesses can provide it, and fewer government programs can promise it for future generations. We need a cure, and we need it now. Harvard Business School’s Clayton M. Christensen—whose bestselling The Innovator’s Dilemma revolutionized the business...
|
|
|
|
